RhoB信号通路失调在结直肠癌放疗抵抗中的关键作用
该研究探讨Rho蛋白是否参与结直肠癌放疗抵抗并研究其机制。通过CRISPR/Cas9建立RhoB敲除细胞系,结合体外实验和斑马鱼胚胎模型分析放射敏感性和侵袭能力,并用质谱流式检测下游信号。结果显示RhoB表达与放疗抵抗相关,RhoB缺失增加放射敏感性并削弱放疗增强的转移潜能,机制涉及Akt和FOXM1通路。
要点
- RhoB表达与结直肠癌放疗抵抗相关。
- RhoB缺失增加放射敏感性并削弱放疗增强的转移潜能。
- RhoB通过Akt和FOXM1通路介导放疗抵抗。
核心结论
- RhoB通过Akt和FOXM1通路在结直肠癌放疗抵抗中起关键作用。
研究设计与样本
- 研究在结肠癌细胞中检测Rho GTP酶表达,用CRISPR/Cas9建立RhoB敲除细胞系,采用体外实验和斑马鱼胚胎分析放射敏感性和侵袭能力,用质谱流式检测RhoB下游信号因子。
- 在参加放疗试验的直肠癌患者中用免疫组化检测RhoB和FOXM1表达。
主要发现
- RhoB表达与放疗抵抗相关。
- 完全敲除RhoB蛋白在体外和斑马鱼模型中增加放射敏感性并削弱放疗增强的转移潜能。
- 基于质谱流式的单细胞信号分析显示放疗后RhoB缺失抑制Akt磷酸化水平。
- RhoB敲除细胞中FOXM1下调,抑制FOXM1导致放疗后细胞存活率降低及迁移和侵袭能力减弱。
- 在接受放疗的患者中,RhoB过表达与高FOXM1、晚期TNM分期、高远处复发和不良生存相关,且独立于其他临床因素。
临床怎么用
- RhoB和FOXM1表达可能作为结直肠癌放疗抵抗和不良预后的评估指标。
- 靶向RhoB及其下游Akt和FOXM1通路可能为克服结直肠癌放疗抵抗提供策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To explore whether the Rho protein is involved in the radioresistance of colorectal cancer and investigate the underlying mechanisms. METHODS AND MATERIALS: Rho GTPase expression was measured after radiation treatment in colon cancer cells. RhoB knockout cell lines were established using the CRISPR/Cas9 system. In vitro assays and zebrafish embryos were used for analyzing radiosensitivity and invasive ability. Mass cytometry was used to detect RhoB downstream signaling factors. RhoB and Forkhead box M1 (FOXM1) expression were detected by immunohistochemistry in rectal cancer patients who participated in a radiation therapy trial. RESULTS: RhoB expression was related to radiation resistance. Complete depletion of the RhoB protein increased radiosensitivity and impaired radiation-enhanced metastatic potential in vitro and in zebrafish models. Probing signaling using mass cytometry-based single-cell analysis showed that the Akt phosphorylation level was inhibited by RhoB depletion after radiation. FOXM1 was downregulated in RhoB knockout cells, and the inhibition of FOXM1 led to lower survival rates and attenuated migration and invasion abilities of the cells after radiation. In the patients who underwent radiation therapy, RhoB overexpression was related to high FOXM1, late Tumor, Node, Metastasis stage, high distant recurrence, and poor survival independent of other clinical factors. CONCLUSIONS: RhoB plays a critical role in radioresistance of colorectal cancer through Akt and FOXM1 pathways.
引用
- Liu N, Cui W, Jiang X, et al. The Critical Role of Dysregulated RhoB Signaling Pathway in Radioresistance of Colorectal Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 31039421. doi:10.1016/j.ijrobp.2019.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。